Bringing innovation to the Healthcare industry.
EMBIO Diagnostics has decisively entered the Healthcare industry with its revolutionary Indoor Air Quality (IAQ) monitor AirBELD, and its infectious disease monitoring device CovBELD.
These two innovative products tap into two key sectors that are currently experiencing massive growth on a global scale.
Indoor Air Quality monitoring devices will prove to be a key factor in eliminating infectious disease spreading, while at the same time, rapid testing kits that provide results in minimum time are a key ally in prompt diagnosis of SARS-Cov-2.
Air BELD
AirBELD is an integrated low-cost monitoring system capable of determining Indoor Air Quality (IAQ) as well as detecting high hazardous incidents for spreading infectious airborne diseases, such as SARS-CoV-2 in the breathing air.
AirBELD can be a key component in common grounds were human activity, in combination with other exterior parameters, affect indoor air quality and favour disease spreading conditions by properly and strategically managing human resources.
This IAQ monitor consists of state-of-the-art sensors and a highly novel system that has been developed by EMBIO Diagnostics Ltd.
state of the art sensors
easy to install
Always on
receive alerts via sms or email
CovBELD
Our revolutionary rapid testing device for Sars-Cov-2 enables measurements on the spot, provides measurement analytics via a dedicated app, and provides results in just 3 minutes.
minutes
%
accuracy
%
specificity
%
sensitivity
Customised services
Being one of the few ISO certified companies in the region, we are able to offer:
Clinical research
Developmental studies
Device performance categorization
Medical device testing
Medical device validation
View our publication: Journal of Virological Methods
